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state and decrease in amyloid burden
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Abstract
Background: Increasing evidence shows an association between the use of vitamin D and improvement in
age-related cognitive decline. In this study, we investigated the possible mechanisms involved in the
neuroprotective effects of vitamin D on age-related brain changes and cognitive function.
Methods: Male F344 rats aged 20 months (old) and 6 months (young) were used and randomly assigned to
either vitamin D supplementation or no supplementation (control). A total of n = 39 rats were used in the
study. Rats were individually housed and the supplementation group received a subcutaneous injection of
vitamin D (1, α25-dihydroxyvitamin D3) 42 I.U./Kg for 21 days. Control animals received equal volume of normal
saline. Behavioral testing in water maze and spontaneous object recognition tasks started on day 14. Levels of
interleukin (IL)-1β and IL-10 were quantified to assess inflammatory state. Also, beta amyloid (Aβ) clearance
and Aβ load were measured.
Results: Our results show that: (1) aged rats demonstrated significant learning and memory impairment overall
compared to younger animals. However, the age-related decline in learning and memory was ameliorated by
the supplementation of vitamin D. No vitamin D effect on learning and memory was seen in the young animals;
2) the pro-inflammatory cytokine IL-1β is significantly increased while the anti-inflammatory cytokine IL-10 is
significantly decreased in the aged rats compared to the young animals; but this age-related change in
inflammatory state was mitigated by vitamin D supplementation. No effects of vitamin D were seen on the IL-1β
and IL-10 expression in the young rats; (3) vitamin D increased Aβ clearance and decreased amyloid burden in
the aged rats while no significant difference was seen between the young animal groups.
Conclusions: Our data suggest that vitamin D supplementation modulated age-related increase in
pro-inflammatory state and amyloid burden. It is possible that these effects of vitamin D mediated the decrease
memory impairment seen in the aged rats making it a useful therapeutic option to alleviate the effects of aging
on cognitive function.
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Background
Vitamin D deficiency is a concern in adults over the age
of 50 years. It is estimated that between 40% and 100%
of older, community-living adults in the United States
and Europe are vitamin D deficient [1,2]. Vitamin D is a
neurosteroid hormone with diverse physiological roles.
Evidence shows that the receptors for vitamin D in the
central nervous system (CNS) are widely distributed and
that the enzyme responsible for the synthesis of the
active form of vitamin D is ubiquitous in the brain [3-5].
Based on this information, it is highly likely that vitamin
D plays a role in neurological functioning. Indeed,
animal studies indicate that vitamin D is important for
brain development [6-8]. Additionally, epidemiological
studies link the plasma level of vitamin D to a range of
brain-related outcomes (reviewed in [4]). Although
data in human studies are not consistent, an association
between low concentrations of vitamin D and impair-
ments in cognitive functions such as memory and orien-
tation, and executive function is reported, as well as
diagnosis of dementia and Alzheimer’s disease [9-14].
Studies in 139 ambulatory nursing home residents with
a history of falls and are vitamin D deficient at baseline
also report improved attention and reaction times after
6 months of supplementation; and a small improvement
in clock drawing performance but not verbal fluency is
seen when vitamin D was given over 4 weeks in 25 eld-
erly nursing home participants [15,16]. Other studies
suggest the possibility that vitamin D may be neuropro-
tective because it plays an important role in the expres-
sion of neurotrophic factors, neurogenesis, calcium
homeostasis, and detoxification [17-20].
Neuronflammation may be an important underlying
mechanism in cognitive decline in the elderly as demon-
strated by emerging evidence on the association between
systemic levels of inflammatory markers to age-related
cognitive impairment [21-23]. Neuroinflammation in
aging is also implicated in pathological events such as
the development of amyloid plaques commonly seen in
Alzheimer’s disease [23]. Data from neurocognitive stud-
ies in populations of older adults living in the commu-
nity also consistently show an association between
higher inflammatory levels and lower cognitive function-
ing (reviewed in [24]). Since evidence shows inflamma-
tion and vitamin D deficiency is common in aging, and
that providing vitamin D supplementation improves age-
related cognitive decline, it is possible that the neuropro-
tective effects of vitamin D involves the modulation of
inflammatory state resulting in decreased formation of
amyloid beta (Aβ) oligomers, a pathological consequence
of chronic inflammation. Thus, in this study we investi-
gated whether vitamin D has the ability to: 1) modulate
the exaggerated pro-inflammatory state associated with
aging, and 2) reduce levels of Aβ oligomers. In addition,
we examined whether the ability of vitamin D to modify
these neuropathological processes is associated with
improved cognitive functioning.
Methods
Subjects
Male F344 rats age 20 months (aged) and 6 months
(young) obtained from Harlan Laboratories (Madison,
WI, USA) were used. Rats were housed individually in a
pathogen-free vivarium under controlled condition
(temperature 22 ± 1°C and humidity 70 ± 5%) and a
14:10 hour light:dark cycle was maintained. All animals
were housed in the same room so that temperature,
humidity, and lighting conditions are similar for all
groups. Animals had free access to food (regular rat
chow containing 3 I.U./g vtamin D3, 1.4% calcium, and
1.1% phosphorus) and water. Animals were also handled
daily throughout the study so that they could get accli-
mated to the research personnel thereby decreasing
stress. Experiments (Figure 1) started 2 weeks after arrival
of the animals and all experimental protocols in this study
were approved by the Institutional Animal Care and Use
Committee and in accordance with the National Institutes
of Health guidelines.
Vitamin D supplementation
Two weeks after arrival from the breeder, young and
aged rats were randomly assigned to either the control
(CON) or vitamin D supplementation groups. A total of
n = 39 rats were used in the study (n =10 animals in
each of the young groups and the aged CON group; n =
9 animals in the aged vitamin D group). The supplemen-
tation group received the active metabolite of vitamin D
(1, α25-dihydroxyvitamin D3; Calbiochem, LaJolla, CA,
USA) 42 I.U./Kg based on our previous work where this
amount of vitamin D and duration of supplementation
produced an elevation of serum levels without any other
side effects (for example, lethargy, weight loss, diarrhea).
Vitamin D was prepared daily and dissolved in 1%
ETOH (diluted with sterile saline). Injections instead of
dietary or water supplementation were chosen to be able
to control the amount of vitamin D given because each
animal’s dietary and water intake is variable. Rats in the
control group received 99% normal saline and 1% ETOH
of equal volume to control for the effects of stress
induced by the injection. Both vitamin D and normal
saline injections were given subcutaneously for a total of
21 days and rats were weighed once a week during the
supplementation regimen and no group differences were
seen. Rats were also monitored daily for possible side
effects (n=0) such as apathy, lethargy, and diarrhea.
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Cognitive testing
Two weeks after vitamin D or saline injections started,
rats were tested in the water maze and Y maze to evalu-
ate cognitive impairment (Figure 1, Study design). Both
tests assessed learning and memory processes. All test-
ing was done approximately 2 h prior to the onset of the
dark cycle to ensure that it is close to the rats’ active
period.
Water maze
Spatial learning and memory (acquisition and recall),
tasks sensitive to hippocampal dysfunction were exam-
ined using the water maze task as previously described
[25,26]. During testing, the water maze tub was filled
with tepid water (22 ± 2 C) and made opaque by
the addition of powdered milk. The pool was divided
into four quadrants of equal surface area and the start-
ing locations for testing were assigned north, south, east,
and west. The goal/platform was located in the middle
of the southeast quadrant approximately 22 cm from the
pool rim. The day before actual testing started, rats
were allowed a habituation swim for 10 s without
the platform. Animals received four trials a day for
4 consecutive days. During the trials, swim latency
(time to reach the platform) and the path taken by
the animals to reach the platform were recorded by a
video camera connected to an image analyzer (Water
Maze System Version 4.20, Columbus, OH, USA). In
addition, swimming speed (path length/swim latency)
was used to assess the motoric activity in performing
the task.
On the last day, a probe trial was performed wherein
the animals were tested in the water maze but the goal/
platform was removed. Measures evaluated in the probe
trial were: amount of time spent in the correct quadrant
where the goal/platform was previously located, and
search errors, which represent the number of entries
made to incorrect quadrants in the pool. An error was
designated only if the rat’s entire body (excluding the
tail) is in an incorrect quadrant.
Y maze
Spontaneous object recognition and temporal order
memory were tested using the Y maze. Rats were habitu-
ated to the Y maze without any objects for 1 min per
day for 3 days to reduce anxiety. Tests in the Y maze
consisted of: novel object preference, object-in-place,
and temporal order memory tasks (Figure 2). All tests
comprised of an acquisition phase (sample phase) and
a recognition phase (test phase), separated by a time
delay. The maze and objects were wiped with a wet cloth
containing sodium hypochlorite solution after each
session to eliminate odor cues. Exploratory behavior was
defined as the animal directing its nose or sniffing
toward the object at a distance of approximately 2 cm.
Other behaviors such as looking around while sitting
on or resting against the object were not considered
exploratory behavior.
The novel object recognition task allows discrimin-
ation between novel and familiar objects. This kind of
memory consists of two components: recollection, which
depends on the hippocampus, and familiarity, which
depends on the perirhinal cortex [27]. In the acquisition
phase, two identical objects (A1 and A2) were placed
near the two diagonal corners of the Y maze and the ani-
mals were allowed to explore the objects for 2 min. The
delay between the sample and test phases was 30 min.
During the test phase, two objects were placed at the
same positions as in the sample phase, and one object
was the same used in the sample phase (A1), while the
other was a novel object (B). The time spent exploring
the novel and familiar objects was recorded for 2 min
but attention was focused on the first minute, during
which rats’ preference for the novel object is typically
greatest [28]. The position of the objects in the test
phase and the objects used as novel or familiar were
counterbalanced between rats.
The object-in-place task was started 2 h after comple-
tion of the novel object recognition test. In this task, the
rat’s ability to recognize objects it had experienced be-
fore that remained in the same location versus those that
Figure 1 Study design. Legend: CON, control; SOR, spontaneous object recognition. Numbers on the horizontal plane represent days.
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had changed location was assessed. In the acquisition
phase, the rat was exposed to objects C1 and C2, and
D1 and D2, which were placed in the Y maze as in the
novel object recognition test and the animal was allowed
to explore all objects for 2 min. After a delay of 60 min,
the test phase began in which objects C1 and C2
remained in the same position but objects D1 and D2
were moved or placed in different locations. Thus, all
objects in the test phase were equally familiar, but
two were in new locations and the other two remained
stationary. The objects moved and the positions of
the objects were counterbalanced between rats. If
object-in-place memory is intact, the animal should
spend more time exploring the two objects that are in
different locations compared to the two objects that are
in the same locations.
Temporal order memory task was started 24 h after
completion of the object-in-place test. This task com-
prised of two sample phases and one test trial. In each
sample phase, the animals were allowed to explore two
copies of an identical object for a total of 2 min.
Different objects were used for sample phases 1 and 2,
with a delay between the sample phases of 30 min. The
test trial (2 min duration) was given 90 min after sample
phase 2. During the test trial, a copy of the object from
sample phase 1 and a copy of the object from sample
phase 2 were used. The positions of the objects in the
test and the objects used in sample phases 1 and 2 were
counterbalanced between the animals. If temporal order
memory is intact, the rats should spend more time
exploring the object from sample 1, that is, the object
presented less recently, compared with the object from
sample 2, that is, the new object.
In all the tasks, the rats were placed in the Y maze
start box and the guillotine door was opened to allow
the rat entry into the main area of the apparatus; the
door was closed immediately once the rats had vacated
the start box to prevent re-entry into this area. Timing
Figure 2 Spontaneous object recognition tasks. Diagrams of the three spontaneous object recognition tasks used in the study: novel object
recognition (A), object-in-place test (B), and temporal order memory (C).
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of the exploration session did not begin until the rat
had exited the start box. The Y shape maze was used to
reduce the spatial and contextual information and
test only object recognition abilities of the animals. All
sessions (acquisition and testing) were taped and
exploration time was calculated after the sessions were
completed. The total time exploring each object and the
discrimination ratio, which is the difference in time
exploring novel and familiar objects divided by the total
time were calculated.
Tissue preparation
All rats were euthanized using CO2 asphyxiation after
behavioral testing, the brains removed, cut in half sagi-
tally and both hippocampi manually dissected then im-
mediately placed in liquid nitrogen and kept frozen until
processed. One half was used for real-time polymerase
chain reaction (RT-PCR) for determination of cytokines
IL-1β and IL-10 messenger RNA (mRNA) levels and the
other half was used for western blot (Aβ oligomers,
BACE1, and neprilysin levels) and ELISA (IL-1β and
IL-10 protein expression).
Real-time polymerase chain reaction
To examine mRNA expression of IL-1β and IL-10, RT-
PCR was used. After 0.1 g of frozen hippocampal tissue
was homogenized in Trizol (Invitrogen, Carlsbad, CA,
USA), total RNA was extracted using an RNeasy extrac-
tion kit (Qiagen, UK) according to the manufacturer’s
protocol. From the RNA, cDNA was synthesized with
oligo primers (listed in Table 1) at 50°C using the Super-
Script III First-Strand Synthesis (MBI Fermentas, Glen
Burnie, MD, USA) following the manufacturer’s instruc-
tions. After reverse transcription, the cDNA was diluted
1:4 (for IL-10) or 1:8 (for IL-1β) and the sample was
amplified by RT-PCR (LightCycler, Roche Diagnostics,
Idaho Falls, ID, USA) using SYBR Green master mix or
TaqMan Universal PCR Master Mix (Applied Biosys-
tems, Foster City, CA, USA) and the following cycling
parameters were used: initial denaturation and enzyme
activation at 95°C for 10 min, followed by 45 cycles
of denaturation at 95°C for 15 s, 61°C for 34 s (IL-1β),
60°C for 34 s (IL-10), or 65°C for 30 s (glyceraldehyde-3-
phosphate dehydrogenase), and extension at 72°C for
1 min. Copy numbers of IL-1β and IL-10 transcripts
were normalized against those of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH, housekeeping gene)
transcripts for each sample. All reactions were performed
in triplicate. For quantitative analysis of target gene mRNA,
the comparative threshold cycle (CT) method was used
[29]. The difference between the normalized threshold
cycle for the vitamin D and saline samples, as well as the
young and aged samples were expressed as fold change.
Cytokine protein quantification
The concentration of IL-1β and IL-10 protein levels was
determined in the hippocampus using commercially
available ELISA assays, following the instructions sup-
plied by the manufacturer (R&D Systems; Minneapolis,
MN, USA). Briefly, 0.2 g of frozen hippocampal tissue
was homogenized with a glass homogenizer in 1 mL
buffer containing 1 mmol/L phenylmethylsulfonyl fluor-
ide, 1 mg/liter pepstatin A, 1 mg/liter aprotinin, and
1 mg/liter leupeptin in PBS (pH 7.2), and centrifuged at
12,000 x g for 20 min at 4°C. The supernatant was col-
lected and total protein was determined by bicinchoninic
acid (BCA) protein assay reagent kit (PIERCE, Milwau-
kee, WI, USA). Standards, controls, and samples (50 μL)
were pipetted into a 96-well plate precoated with poly-
clonal antibodies specific for IL-1β and IL-10, then incu-
bated at room temperature for 2 h on an orbital plate
shaker (approximately 250 rpm) then washed 5x before
adding the conjugate. After several washes, the chromo-
gen (tetramethylbenzidine) was added to each well and
incubated for an additional 30 min. Color reaction was
stopped by an equal volume of stop solution and reac-
tion was read in a microplate reader (Bio-Tek, Winooski,
VT, USA) at a wavelength of 450 nm (650-nm reference
wavelength). The color change was proportional to the
concentration of the cytokines measured and all samples
measured within the range of the standard curve. This
ELISA system detects both natural and recombinant rat
IL-1β and IL-10. Assays were sensitive to 1.5 pg/mL of
IL-1β and 10 pg/mL of IL-10, and inter- and intra-assay
coefficients of variation were <10%.
Western blot
To detect levels of Aβ oligomers, BACE1, and neprily-
sisn, 0.5 g of frozen hippocampal tissue was used in the
western blot procedure. Tissues were homogenized and
centrifuged at 25,000 x g for 20 min as previously
described [25,26]. Aliquots from the supernatant were
Table 1 Oligo primers
Forward Reverse
IL-1β 5’-AAGCCTCGTGCTGTCGGACC-3’ 5’-TGAGGCCCAAGGCCACAGGT-3’
IL-10 5’-GGCATGAGGATCAGCAGGGGC-3’ 5’-TGGCTGAAGGCAGTCCGCAG-3’
GAPDH 5’-AGACAGCCGCATCTTCTTGT-3’ 5’-CTTGCCGTGGGTAGAGTCAT-3’
Primer sequences for RT-PCR were designed using Applied Biosystem’s Primer Express software.
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removed for protein determination. Protein concentra-
tion in samples was determined using the BCA-Protein
assay (Pierce, Rockford, IL, USA). The primary anti-
bodies used are: (1) anti-BACE1 (1:50, Calbiochem, San
Diego, CA, USA) to evaluate βamyloid precursor protein
processing; and (2) anti-neprilysin (1:50, Novocastra
Laboratories, Newcastle upon Tyne, UK) to evaluate
levels of Aβ degrading enzyme.
Western blot procedure was also used to examine for-
mation of Aβ oligomers. After tissue homogenization as
described above, some of the samples were removed for
extraction of soluble amyloid peptide. Samples were
centrifuged at 78,500 x g for 1 h at 4°C and the super-
natant were removed then processed as described above.
Antibody used was anti-A11 (1:200, Biosource, Carlsbad,
CA, USA) to determine levels of Aβ oligomers.
For western blot analyses, equal amounts of protein
(40 μg) from each rat were loaded and separated by
SDS-PAGE gel electrophoresis in 8% to 16% acrylamide
gradient gels. The protein bands were electrophoretically
transferred to nitrocellulose membranes (Amersham, Pis-
cataway, NJ, USA) stained with 0.5% Ponceau Red
to visualize total proteins, then destained. Non-specific
binding sites were blocked then nitrocellulose membranes
were incubated overnight at 4°C with gentle agitation
in the primary antibody. The secondary antibodies used
are horseradish peroxidase-conjugated immunoglobulin
(Sigma, St. Louis, MO, USA) and the Super Signal chemi-
luminescense substrate kit (Pierce, Rockford, IL, USA)
was used to visualize immunoreactive bands. After
visualization, the membranes were then stained with
Amido-Black to qualitatively verify protein loading. A
series of dilutions were performed and immunoblotted
for each antibody to establish that the relationship be-
tween protein band and intensity was linear over the
range of band intensities observed in the samples. Band
visualization was obtained by exposure of membranes to
autoradiographic film (Kodak Biomax™). Samples were
analyzed in quadruplicates and measurements were aver-
aged and used as one individual data point for statistical
analysis. Quantification of differences in protein bands be-
tween samples was done using densitometric analysis
(Scion Image Beta 4.0.2; Frederick, MD, USA). The in-
ternal control β-actin was used to standardize experimen-
tal values in densitometric analysis. Densitometric values
were calculated as: density of sample band/density of
background. Values obtained were then converted to per-
cent of young group (approximately 100% ± 3%) since
vitamin D did not have any significant effects on BACE1
levels, Aβ clearance, and Aβ burden in these animals.
Detection of plasma vitamin D levels
Plasma levels of activated 1, α25-dihydroxyvitamin D3
were determined using the commercially available ELISA
assay (Immunodiagnostic Systems, Fountain Hills, AZ,
USA) according to manufacturer’s instructions. After
CO2 asphyxiation, the thoracic cavity was opened and
blood collected from cardiac puncture was placed in
EDTA coated tubes. Samples were centrifuged (6,000 x g
for 15 min at 4°C) and stored at 80°C until assaying.
Briefly, controls and samples were delipidated and trans-
ferred to supplied immunocapsules containing monoclo-
nal antibody to 25(OH)D or 1, α25-dihydroxyvitamin D3
in suspension with vitamin D-binding protein inhibitor
for immunoextraction. After eluting calcidiol from the
immunocapsule gel, samples were evaporated in boro-
silicate glass tubes in a heating block for 30 min under
nitrogen gas flow. Evaporated samples were reconsti-
tuted in assay buffer and incubated overnight with 100
μL of primary antibody solution. Standards, controls,
and samples were then pipetted into a 96-well plate pre-
coated with antibodies specific for 1, α25-dihydroxyvita-
min D3 then incubated at room temperature for 90 min
on an orbital plate shaker. Subsequent steps are similar
to those described above for cytokine quantification.
Statistical analysis
The SAS general linear model (SAS Institute, North
Carolina, USA) procedures for two-way analysis of vari-
ance (ANOVA) were used to examine effects of experi-
mental conditions (vitamin D vs saline groups) and age
(young vs aged) on the dependent variables. Two-way
repeated measures ANOVA was used to examine vita-
min D supplementation effects on behavioral perform-
ance on the water maze to determine differences in
swim latency, path length, and swimming speed. When
appropriate, the SAS CONTRAST statement was used
for planned comparisons of the effects of supplementa-
tion (vitamin D vs saline groups) and age (young and
aged), and the combination of age and supplementation.
All error bars represent ± standard error of the mean
(SEM) of the sample size used in the study.
Results
Plasma levels of vitamin D
To determine age-related vitamin D changes we mea-
sured circulating levels of its active form, vitamin D, 1,
α25-dihydroxyvitamin D3, and found significantly lower
levels in the aged rats when compared to the young ani-
mals (Figure 3); but the deficiency seen in the aged rats
that received the supplementation was significantly less
in comparison to the aged CON animals. Post hoc com-
parisons showed a significant 1, α25-dihydroxyvitamin
D3 deficiency in the aged CON rats to less than 26% of
the young CON group suggesting an age-related vitamin
D deficiency. Further analysis revealed circulating levels
of 1, α25-dihydroxyvitamin D3 is 32% in the aged CON
rats compared to the aged animals that received the
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supplementation. No significant differences were evident
in circulating levels of 1, α25-dihydroxyvitamin D3
in the young animal groups. These results suggest an
age-related deficiency in vitamin D metabolism.
Vitamin D mitigates age-related cognitive decline in the
water maze task
Rats were tested in the water maze after ensuring intact
visual skills. A significant within-subjects effect was
seen for swim latency across the test days given that all
rats learned the task over the 4 testing days. An overall
significant main effect of age was seen in mean swim
latency (Figure 4A) and the aged CON group demon-
strated longer mean swim latency overall compared to
all groups. Meanwhile, a significant main effect of vita-
min D was also seen in that the aged rats that received
vitamin D demonstrated decrease mean swim latency
compared to the aged CON group. Although the aged
vitamin D group performed significantly better when
compared to the aged CON rats, they still demonstrated
impairment in comparison to the young animal groups.
No significant difference was seen in mean swim latency
between the young animal groups. Additionally, no
interaction effect was seen between age and vitamin D
in mean swim latency but a significant interaction effect
was seen in swimming speed (P = 0.031) with longer
times seen in the aged animal groups.
Measurement of path length also showed significant
within-subjects effect (Figure 4B) where all rats showed
a continuous decrease in the swimming distance cov-
ered to reach the platform across the test days. Overall
significant main effects of age and vitamin D were seen
where the aged CON animals frequently used the indir-
ect path to reach the goal compared to all groups while
the aged vitamin D group performed better but still
showed impairment in comparison to the young animals.
No significant difference was seen when the young ani-
mal groups were compared. A trend toward an inter-
action effect (P = 0.06) was seen between age and
vitamin D in mean path length. Taken together, the
swim latency and path length results suggest that the
rats were able to determine their location in space, and
adjust their behavior accordingly but this behavior just
took longer to accomplish in the aged animals; however,
giving vitamin D to the aged rats helped lessen this cog-
nitive decline.
In the probe trial (long-term memory recall phase)
time spent swimming in the quadrant of the pool where
the goal/platform was previously located (correct quad-
rant) was divided by the time spent swimming in the
other three quadrants of the pool (wrong quadrants).
Aged CON rats showed significant impairment overall
(Table 2) when compared to all groups. In contrast, aged
rats that received vitamin D supplementation performed
slightly better but still spent more time in the incor-
rect quadrant area and made more search errors when
compared to the young animal groups. No significant
Figure 4 Water maze task. Performance in the water maze shows significant impairment in the aged rats in swim latency (A) in comparison to
the young animals with the greatest deficit seen in the aged control group. Analysis of path taken to reach the goal (B) also show that the aged
rats was significantly impaired compared to the young animal groups but the aged rats that received vitamin D supplementation performed
slightly better. *P <0.05, **P <0.01. Legend: CON, control.
Figure 3 Plasma levels of vitamin D. Plasma circulating levels
show significant deficiency in the aged rats when compared to
the young animals in the active form of vitamin D. However,
supplementation of vitamin D mitigated this deficiency. *P <0.05.
Legend: CON, control.
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differences were seen in the probe trial performance of
the young rats. These results suggest that long-term
memory recall is also affected by age and that vitamin D
supplementation diminished this cognitive impairment.
Vitamin D mitigates age-related cognitive decline in the
spontaneous object recognition task
Analysis of performance in the novelty recognition task
showed no significant main effect of age and vitamin D
in exploration times during the sample phase. Separate
analysis of exploration times in the test phase also
showed no significant group differences as seen in
Table 3. Furthermore, discrimination ratio on the test
phase showed no significant main effect of age nor vita-
min D wherein all rats demonstrated the ability to dis-
criminate between the familiar and novel objects even
after a time delay between the sample and test phases
(Figure 5A). As well, no significant interaction effect was
seen between age and vitamin D in both total explor-
ation times and discrimination ratio. These results sug-
gest that hippocampal aging does not affect the animals’
ability to recognize simple novelty.
When performance was evaluated in the object-in-
place task, our results showed that exploration time in
aged animals was not significantly different from the
young rats after a 30 min delay (Table 3). However,
significant main effects of age and vitamin D were seen
in discrimination ratio where it is lower in aged rats
compared to the young animals (Figure 5B) but aged
rats that received vitamin D supplementation showed
slightly better performance when compared to the aged
CON rats. Comparison of the young animals showed
no significant difference in discrimination ratio in the
object-in-place task. These results suggest that aged
animals lacked the ability to differentiate between the
non-rearranged and rearranged objects but vitamin D
was able to mitigate this impairment.
Analysis of recognition in the temporal order memory
test after a 90-min delay revealed a significant main
effects of age and vitamin D in exploration time as seen
in Table 3. Post hoc testing confirmed that exploration
time of the aged control animals was significantly worse
when compared to all groups. But aged rats given vita-
min D supplements showed improvement in exploration
time when compared to the aged CON animals even
though their performance is still impaired in comparison
to the young rats. No significant difference was seen in
exploration time between the young animal groups.
Analysis of discrimination ratio showed that aged rats
were less able to discriminate between the objects pre-
sented earlier and the one presented recently when com-
pared to the young animal groups (Figure 5C). Although
aged rats that received vitamin D supplements failed to
significantly discriminate between the objects in the
temporal order memory task when compared to the
young rats, their performance is not as worse as the aged
CON animals. These results suggest the possibility that
vitamin D may be able to ameliorate age-related cogni-
tive decline in distinguishing complex stimuli.
Vitamin D modulates the age-related changes in
inflammatory state
To determine whether vitamin D can improve the bal-
ance between pro- and anti-inflammatory states that may
be disrupted in aging, we examined mRNA and protein
levels of IL-1β and IL-10 in the hippocampus. Results
reveal that both aged groups have significantly increased
levels of the pro-inflammatory cytokine IL-1β mRNA
when compared to the young animals (Figure 6A) with
aged CON rats demonstrating an overall higher levels.
Table 2 Behavioral performance in the Probe Trial
Errors (n) Time spent in correct quadrant (%)
Young CON 1.51 ± 0.27 62% ± 2.93
Young vitamin D 1.60 ± 0.32 65% ± 3.40
Aged CON 3.25 ± 0.21a 41% ± 3.17a
Aged vitamin D 2.49 ± 0.35b 52% ± 3.02b
Aged CON rats made more mistakes in the probe trial compared to all groups,
while the aged rats that received vitamin D supplementation performed
slightly better but still remained impaired when compared to the young rats.
aP <0.01.
bP <0.05.
Table 3 Exploration time in the spontaneous object recognition tasks
Novel object preference Object-in-place Temporal order memory
Sample phase Test phase Test phase Test phase
Young CON 49.7 ± 2.21 47.5 ± 3.01 31.1 ± 3.47 33.3 ± 2.51
Young vitamin D 48.2 ± 2.93 45.9 ± 2.99 34.4 ± 3.72 35.2 ± 1.88
Aged CON 47.8 ± 1.97 46.9 ± 3.15 23.7 ± 4.34a 20.1 ± 2.43a
Aged vitamin D 49.3 ± 2.10 47.5 ± 3.07 29.9 ± 4.40 11.9 ± 2.16b
Mean exploration time expressed in seconds(s) during the sample and test phases in the novelty recognition test, and during the test phases in the
object-in-place and temporal order memory tests. No significant differences were seen in exploration time during the novelty recognition and object-in-place
tests. Meanwhile, aged CON rats showed significantly decrease exploration time in the object-in-place and temporal order memory tests after a time delay.
aP <0.05 (significantly different from the young animal groups). **p <0.01 (significantly different overall).
bP <0.01 (significantly different overall).
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Levels of IL-10 mRNA is also significantly elevated
in both aged groups compared to the young rats but IL-
10 mRNA levels in aged rats that received vitamin D
supplementation was greater in comparison to the aged
CON group. Similar pattern of expression is seen in IL-
1β and IL-10 protein expression. Furthermore, analyses
of IL-1β and IL-10 protein levels (Figure 6B) show simi-
lar pattern of expression as those seen in mRNA. Both
young animal groups show minimal expression of IL-1β
and IL-10 mRNA as well as protein in the hippocampus
and no vitamin D effect is seen. These results suggest
that vitamin D may be able to restore the disrupted
equilibrium between the pro- and anti-inflammatory
states seen in aging.
Vitamin D facilitates Aβ clearance and decrease
amyloid burden
We examined whether age-related neuroinflammation is
associated with increased formation of Aβ oligomers
and if this amyloid oligomerization results from either:
(1) increased alternative processing of the amyloid pre-
cursor protein through the amyloidogenic pathway;
or (2) decreased clearance of beta amyloid. Increased
alternative processing of the amyloid precursor protein
Figure 5 Discrimination ratio in the spontaneous object recognition tasks. Performances in the novelty object test (A) show no
significant differences in all groups. However, aged rats showed significant impairment in discriminating between the objects presented in
the object-in-place test (B) and temporal order memory test (C) compared to the young animals but vitamin D supplementation ameliorated
this cognitive impairment. *P <0.05. Legend: CON, control.
Figure 6 IL-1β and IL-10 expression. Upper panel: IL-1β expression. Lower panel: IL-10 expression. A significant elevation in IL-1β mRNA and
protein expression was seen in the aged rats in comparison to the young animals but vitamin D supplementation mitigated the increase seen in
this pro-inflammatory cytokine in the hippocampus. Levels of IL-10 mRNA and protein also increased in aging as compared to the young rats but
vitamin D supplementation significantly augmented the age-related increase in this anti-inflammatory cytokine. *P <0.05. Legend: CON, control.
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through the amyloidogenic pathway is initiated by the β-
secretase amyloid cleaving enzyme (BACE) and can lead
to the accumulation of Aβ oligomers. We observed sig-
nificant increase in the formation of amyloid oligomers
in the hippocampus of aged rats (35% and 18% greater
in the aged CON and aged vitamin D groups, respect-
ively) compared to the young animals (Figure 7B). How-
ever, giving vitamin D supplementation significantly
reduced Aβ oligomerization by 22% when compared to
the aged CON. No significant difference in the forma-
tion of Aβ oligomers was seen in the young animals.
These results suggest that vitamin D was able to lessen
the formation of the toxic form of the Aβ peptide com-
monly associated with aging.
Additional analysis revealed that the pattern of BACE1
expression seen in the aged rats is similar to that of Aβ
oligomers (Figure 7A) further confirming that aging may
be related to increased processing of the full-length
amyloid precursor protein by the amyloidogenic or alter-
native pathway facilitated by the β-secretase complex,
thus generating more amyloid peptides. Vitamin D sup-
plementation on the other hand, was able to modulate
BACE1 expression in the aged rats. BACE1 expression
in the aged vitamin D animals was approximately 24%
lower than the aged CON animals. But our data did not
reveal any discernable impact on BACE1 expression in
the young rats.
To assess the possibility that the reduction in the for-
mation of Aβ oligomers seen in the aged rats that
received vitamin D may also be a result of increased
degradation or clearance of beta amyloid, we examined
levels of the classical Aβ-degrading enzyme neprilysin
(NEP) in the hippocampus. Our results revealed a sig-
nificant main effect of age in that aged rats show
decreased NEP levels (28% and 17% less in the aged
CON and aged vitamin D, respectively) compared to
the young animals (Figure 7C). A significant main effect
of vitamin D is also seen in older rats that received
the supplement where NEP levels significantly increased
(15% more) compared to the aged CON animals. No
significant difference was seen in levels of NEP in the
young animal groups. These results suggest that the
activity of the Aβ degradation pathway mediated by
NEP decrease with age and that providing vitamin D
Figure 7 Beta amyloid clearance. Significant elevation of β-secretase amyloid cleaving enzyme (BACE1) level (A) led to increased production of
Aβ oligomers (B) in the aged rats when compared to the young animals. Moreover, the significantly reduced levels of neprilysin (NEP), classical
amyloid-degrading enzyme (C), in the aged control rats when compared to the aged vitamin D group possibly decreased amyloid clearance.
Nonetheless, the development of this age-related neuropathology was abated by vitamin D supplementation. *P <0.05. Legend: A, aged; CON,
control; vit, vitamin; Y, young.
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supplementation may be helpful in improving this age-
related change in amyloid clearance.
Discussion
In the present study we demonstrate that age-related
vitamin D deficiency is associated with enhanced pro-
inflammatory state, increased formation of Aβ oligomers,
and reduced amyloid clearance in the hippocampus and
that these neuropathological processes are accompanied
by cognitive decline. To our knowledge this is the first
study to link the neuro-immune effects of vitamin D in
the normal aging brain. Vitamin D is an important hor-
mone with well-characterized effects in the whole body
system in early life as well as in later life. In the past dec-
ades, our knowledge about vitamin D and its biological
activity has significantly improved. Reports on vitamin D
deficiency in the elderly [1,12,13] is extended in the find-
ings of the present study where we show that aged ani-
mals are deficient in the active form of vitamin D, 1,
α25-dihydroxyvitamin D3, when compared to the young
animals. The age-related deficiency in vitamin D demon-
strated here may be due to decrease production and/or
increase metabolic clearance rate because of the high
levels of 24-hydroxylase, the enzyme that metabolize
vitamin D, seen in the elderly (reviewed in [30]). The
lack of significant difference in circulating levels of 1,
α25-dihydroxyvitamin D3 in the young animals is hard
to explain but it may be that the amount of supplement
used in the present study is not high enough to cause an
increase in plasma levels in conditions where no defi-
ciency exist.
Biological effects of vitamin D supplementation in
aging are illustrated in our findings. Here we demon-
strate an age-related disruption in the homeostatic bal-
ance between the common pro- and anti-inflammatory
cytokines, which parallel findings from previous reports
[22,24,31,32]. We also show that supplementation with
the active form of vitamin D modulated the age-related
changes in pro-inflammatory state where the anti-
inflammatory cytokine IL-10 increased while the pro-
inflammatory cytokine IL-1β decreased. Because vitamin
D plays a regulatory role in inflammation (reviewed in
[30]), its deficiency can promote a chronic pro-
inflammatory state that can have deleterious effects in
the brain. For example, the pro-inflammatory cytokine
IL-1β plays a role in amyloid precursor protein proces-
sing and promotes Aβ production [33]. Increase Aβ
production then results in secretion of more pro-
inflammatory cytokines, thus augmenting amyloid toxicity
[34]. Indeed, our study show that the upregulation in IL-1β
seen in the aged CON rats is accompanied by increase
production of the ‘toxic’ Aβ oligomers through the pro-
cessing of the amyloid precursor protein via the amy-
loidogenic pathway facilitated by BACE; and this is
confirmed by our data that BACE1 levels is elevated in
the hippocampus of the aged CON rats.
The immune system’s innate response to curb chronic
inflammation is possibly mediated by vitamin D by regu-
lating the release of anti-inflammatory cytokines such as
IL-10. The role of IL-10 in controlling and terminating
CNS inflammation has been widely reported [35] as well
as its ability to inhibit Aβ effects [36]. Data from the
present study extend previously reported findings
[35,36] where we show that significantly increased IL-10
expression in the aged rats that received vitamin D is
associated with a significant decreased in IL-1β suggest-
ing possible restoration in the homeostatic balance of
inflammatory mediators that may be disturbed in aging.
An unexpected finding is the significant increase in
IL-10 levels in the aged CON rats compared to the
young animal groups and a possible explanation for this
is that it is a compensatory mechanism for the increased
pro-inflammatory state associated with aging to counter-
balance the increase in IL-1β. The vitamin D-mediated
upregulation of IL-10 in the aged rat brain is particularly
important because it possibly mediated the reduction in
risk for developing neuropathology by decreasing BACE1
levels and consequent formation of Aβ oligomers.
The mechanism whereby vitamin D regulates Aβ bur-
den is most likely related to its ability to regulate amyl-
oid clearance. Balance between the synthesis of Aβ from
the amyloid precursor protein and the removal of this
peptide by amyloid-degrading enzymes is an important
factor in determining amyloid clearance preventing its
accumulation thereby decreasing Aβ burden. It has been
suggested that accumulation of Aβ may be explained by
a reduction in the catabolic activity of Aβ-degrading
enzymes such as NEP. Here we show that NEP level
is significantly decreased in the aged rats compared to
the young rats but this reduction in amyloid degrading
enzyme is mitigated by vitamin D supplementation. The
decreased catabolic activity of amyloid-degrading enzymes
seen in aging may be due to the system being over-
whelmed by the increased production of Aβ so that NEP
levels were depleted faster compared to the young rats.
Taken together, our data show that the modulation of
the pro-inflammatory state after vitamin D supplementa-
tion in the aged animals is associated with minimizing
the pathological consequences of neuroinflammation evi-
denced by the reduction of BACE1 level and the conse-
quent reduction in Aβ oligomer formation. Aβ is a
regulatory peptide produced during normal brain meta-
bolism and its steady-state concentration is tightly con-
trolled by amyloid-degrading proteolytic enzymes [37].
The combination of increased Aβ formation and
decreased amyloid-degrading enzyme seen in aging can
lead to an elevated amyloid burden. Since our data show
that vitamin D supplementation in aging can both
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minimize the formation of Aβ oligomers and increase the
activity of the amyloid-degrading enzyme NEP, it stands to
reason that this hormone can be neuroprotective by redu-
cing amyloid burden and facilitating amyloid clearance.
Vitamin D is also implicated in regulating behavioral
functions. In the present study we examined vitamin D
effects of a broad range of memory processes. In this
study we show an attenuation of cognitive deficits in the
aged rats given vitamin D supplements compared to
the aged CON group when tested in the water maze.
The two key findings are: (1) decreased mean swim la-
tency and path taken to reach the goal in the aged vita-
min D group when compared to the aged CON group;
and (2) increased memory recall during the probe trial in
the aged rats given vitamin D in comparison to the aged
CON animals. Although all rat groups seemed to exhibit
the ability to learn the task of reaching the goal, the aged
CON rats persistently show increased time and longer
path taken to reach the goal, as well as decreased ability
to remember the previous location of the goal; however,
age-related impairment in the water maze performance
is diminished by vitamin D supplementation suggesting
that this neurohormone may be able to attenuate aged-
related memory decline. Of the behavioral measures used
in the water maze, it is possible that mean swim
latency may be the least sensitive. That is, the increased
swim latency demonstrated by the aged vitamin D group
may be more related to age-related decrease in motoric
activity and not an indication of cognitive decline. This
line of reasoning is supported by our data that the aged
vitamin D group took a more efficient path to reach the
goal when compared to the aged CON animals and that
we did see a significant difference in swimming speed.
Spontaneous object recognition memory is a more
complex test that uses information such as relative
familiarity of an object or location or when or where an
object is previously encountered to make decisions.
Spontaneous object recognition tasks involve not only
hippocampal functioning but also the medial prefrontal
cortex as well as the perirhinal cortex. In the present
study we demonstrate that aging had no influence
on an animal’s ability to recognize object novelty. But
the rat’s recency memory and ability to recognize the
rearrangement of objects previously encountered are
impaired evidence by significantly decrease discrimina-
tion ratio in the object-in-place and temporal order
memory tests. Nevertheless, vitamin D supplementation
ameliorated the age-related impairment in object-in-
place and temporal order memory tasks. The impair-
ments in the object-in-place and temporal order memory
tasks are most likely due to functional alterations in the
medial prefrontal and perirhinal cortices, and the hippo-
campus, which probably occur during aging leading to
increased vulnerability to the interfering effects of stimuli
encountered during a delay period. The increased vulner-
ability to interference may be due to the inability to dis-
tinguish between complex stimuli that share common
features. Since vitamin D receptors are widely distributed
in the cortex and hippocampus [3-5], it is possible that
the supplementation allowed more circulating hormone
to exert its biological function thereby minimizing cogni-
tive decline.
Conclusion
In sum, the results presented in this study demonstrate
that vitamin D deficiency is common in aging and that
low levels of vitamin D seen in the aged rats are asso-
ciated with increased odds of cognitive impairment.
Supplementation of vitamin D was able to improve age-
related cognitive decline and the possible mechanism
whereby this neurohormone exert its beneficial function
is by modulation of immune function by restoring the
balance between pro- and anti-inflammatory cytokine
secretions, which may be lost in aging. By controlling
pro-inflammatory cytokine secretion, vitamin D mini-
mizes the risk for neuropathological consequences such
as decreasing Aβ burden and increasing amyloid clear-
ance. The amount of vitamin D supplement used in the
study did not completely reverse age-related changes
to the point that both behavioral and biochemical mea-
sures return to levels comparable to the young animal
groups but our results demonstrate that it is more than
adequate to minimize functional deficits and amplifica-
tion of the vulnerability in developing neuropathology
associated with aging. Although this study does not
prove a causal relationship between vitamin D and neu-
rological function, the data presented suggest an immense
potential for this neurohormone to modify age-related
impairment in cognitive and biological functioning. Given
that neurodegeneration and cognitive impairment are
likely to play a central role in the healthcare system and
society in the near future, correction of vitamin D defi-
ciency is an easy, inexpensive, and safe way to modify the
risk factors associated with aging.
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